Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice

Fig. 1

Effects of SCP on the pathomorphology of liver and hepatic lipid content in NAFLD mice. a H&E stained sections of liver tissue (×100); b Quantitative analysis of hepatic total cholesterol (TC) and triglyceride (TG) content. Mice in SCP group were administered SCP at 100 mg/kg/day for 12 weeks. Data are expressed as means ± SD (n = 10). Between-group differences were assessed using one-way ANOVA with post hoc test. * P < 0.05 vs. CON and CON + SCP groups; # P < 0.05 vs. model group. SCP, Schisandra polysaccharide; NAFLD, non-alcoholic fatty liver disease; H&E, hematoxylin and eosin; SD, standard deviation; ANOVA, analysis of variance

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X